newsfilter
← Latest News
Business Wire·

BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights

- Announced positive findings from the Phase 2b SOOTHE trial administrative interim analysis, with at least one dose of BLU-5937 meeting the threshold for a high probability of clinical efficacy - - Phase 2b SOOTHE and Phase 2a BLUEPRINT trials are f